NL-OMON36957
Completed
Not Applicable
Standardized procedure for the assessment of new-to-market continuous glucose monitoring systems - SPACE2
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 6
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\* aged 18 years or above
- •\* diagnosed with Type 1 diabes mellitus at least 6 months according to the WHO definition
- •\* Body Mass Index (BMI) \<35 kg/m²
- •\* HbA1c \<10%
Exclusion Criteria
- •use of medication which could influence glucometabolism
- •use of paracetamol
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Standardized procedure for the assessment of new-to-market continuous glucose monitoring systems.diabetes10018424NL-OMON36537Academisch Medisch Centrum4
Completed
Not Applicable
Standardized Procedure for the Assessment of new-to-market Continuous glucosE monitoring systemsISRCTN01687353Academic Medical Centre (Netherlands)20
Recruiting
Not Applicable
Validation and Standardization of a tool to assess mental strengthCTRI/2023/08/056962Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital Hassan
Completed
Not Applicable
Implementation of a standardized initial assessment as a basis for demand management in outpatient emergency carePatients with subjectively felt urgent need for medical advice and/or treatmentDRKS00017014aQua-Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH552,271
Completed
Not Applicable
How does the regular standardized assessment of antipsychotic-induced side effects in forensic psychiatric patients affect the management of these side effects?Mental and Behavioural Disorders: PsychosisMental and Behavioural DisordersPsychosisISRCTN20829222Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)60